Punjab Province in Pakistan approves first Child Protection Policy    Moon Hall Cairo Opens June 15 as Egypt's First Centre for Learning Difficulties    CBE: Egypt's annual core CPI inflation quickens to 13.1% in May    Egypt's FM hails decade of strategic ties with China    Egypt's gold reserves inch up to $13.679b in May – CBE    Egypt's Sisi, UAE's Bin Zayed discuss Gaza ceasefire, regional stability    Microsoft offers free AI cybersecurity to European govt.    Egypt's EHA partner with Entlaq to advance health sector digitalisation    Egypt plans largest-ever Arafat Day meal distribution, citing national unity    Germany's service sector contracts sharply in May '25    Egypt's EDA holds strategic talks with Pi Pharma    Egypt unveils comprehensive new export rebate programme    Egypt's Abdelatty, Benin FM discuss bilateral ties, African security    Egypt pledges stricter controls on psychotropic drugs amid concerns over misuse, smuggling    Egypt hosts 3rd International Climate, Environment Conference to advance sustainable innovation    Egyptian FM, visiting Indian MPs discuss strategic ties, regional security    Three real estate platforms seek FRA licensing for investment funds    Egypt details economic strategy, private sector empowerment to Goldman Sachs    Egypt, Serbia explore cultural cooperation in heritage, tourism    Egypt discovers three New Kingdom tombs in Luxor's Dra' Abu El-Naga    Egypt launches "Memory of the City" app to document urban history    New Alamein City to host Egypt International Sculpture Symposium, "ART SPACE"    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    Egypt unearths rare Coptic-era structure in Asyut    Amun-Mes named as owner of Luxor's Kampp 23 tomb after 50-year mystery    Egypt's Democratic Generation Party Evaluates 84 Candidates Ahead of Parliamentary Vote    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Cabinet approves establishment of national medical tourism council to boost healthcare sector    Sudan conflict, bilateral ties dominate talks between Al-Sisi, Al-Burhan in Cairo    Egypt's PM follows up on Julius Nyerere dam project in Tanzania    Egypt's FM inspects Julius Nyerere Dam project in Tanzania    Egypt's FM praises ties with Tanzania    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Study links Prozac, Paxil use with birth defects
Antidepressants Prozac and Paxil fou to cause birth defects, Oloft, went off the hook
Published in Ahram Online on 13 - 07 - 2015

A sweeping government study of thousands of women has found links between the older antidepressants Prozac and Paxil and birth defects, but has cleared other popular treatments in the class, including Celexa, Lexapro and Pfizer's Zoloft, which is the subject of a major lawsuit over birth defect claims.
Earlier studies had raised questions about antidepressants in a class of drugs known as Selective Serotonin Reuptake Inhibitors or SSRIs, prompting the U.S. Food and Drug Administration in 2005 to issue a safety warning about use of the treatments during pregnancy.
In the current study, published in the British Medical Journal, researchers at the U.S. Centers for Disease Control and Prevention wanted to see if the birth defect risk affected the entire class of drugs, or only select treatments.
For the study, the researchers asked nearly 28,000 women if they took Celexa, Lexapro, Prozac, Paxil or Zoloft any time from one month before conception through the third month of pregnancy and analyzed which women bore children with birth defects.
They found that many popular antidepressants - Celexa, Lexapro or Zoloft - are not associated with birth defects. Only two in the study, Prozac, sold generically as fluoxetine, and Paxil, sold generically as paroxetine, were implicated.
In women who took those two drugs early in pregnancy, birth defects occurred 2 to 3.5 times more frequently compared with women who did not take them.
Prozac use was associated with a birth defect in which a baby's skull is misshapen. Paxil use was associated with a defect in which a baby's intestines protrude outside the body and with anencephaly, in which a baby is missing parts of the brain and skull, the study found.
Both Paxil and Prozac were linked to a heart defect.
The study's authors noted that the risks appeared to be small. For example, in women who took paroxetine early in pregnancy, the risk for anencephaly rose from 2 cases per 10,000 to 7 per 10 000.
The analysis was only able to show links between the drugs and birth defects, but could not prove that the drugs caused the deformities. The authors called the findings about Zoloft "reassuring" because the drug was used by some 40 percent of the women in the study who said they had used an antidepressant in early pregnancy.
http://english.ahram.org.eg/News/135323.aspx


Clic here to read the story from its source.